Genome&Company
Develops microbiome drugs and novel immune checkpoint inhibitors for immuno-oncology.
314130 | KO
Overview
Corporate Details
- ISIN(s):
- KR7314130006
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 창룡대로256번길 50 7층, 8층, 수원시
- Website:
- http://genomecom.co.kr/
- Sector:
- Manufacturing
Description
Genome&Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's research and development pipeline is centered on two primary platforms: microbiome-based pharmaceuticals and novel immune checkpoint inhibitors for immuno-oncology. Its drug candidates are derived from its proprietary microbiome platform and are aimed at treating a range of diseases, with a significant focus on cancer. In addition to its pharmaceutical programs, the company develops and markets consumer healthcare products, including dietary supplements and cosmeceuticals, leveraging its expertise in microbes and probiotics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-08 00:00 |
전환가액의조정
|
Korean | 10.6 KB | ||
| 2024-08-08 00:00 |
전환가액의조정
|
Korean | 10.2 KB | ||
| 2024-08-05 00:00 |
권리락 (무상증자)
|
Korean | 3.5 KB | ||
| 2024-08-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 91.6 KB | ||
| 2024-07-22 00:00 |
주권매매거래정지 (무상증자)
|
Korean | 4.8 KB | ||
| 2024-07-22 00:00 |
주요사항보고서(무상증자결정)
|
Korean | 21.9 KB | ||
| 2024-07-19 00:00 |
증권발행결과(자율공시)
|
Korean | 5.6 KB | ||
| 2024-07-18 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2024-07-17 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 63.9 KB | ||
| 2024-07-01 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2024-06-28 00:00 |
기타시장안내 (업종변경 안내)
|
Korean | 4.7 KB | ||
| 2024-06-26 00:00 |
[기재정정]투자판단관련주요경영사항 (GENA-111 기반 항체-약물접합체ADC 개발 및 상업화 기술이전 계약 체결)
|
Korean | 14.7 KB | ||
| 2024-06-05 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2024-06-03 00:00 |
투자판단관련주요경영사항 (GENA-111 기반 항체-약물접합체ADC 개발 및 상업화 기술이전 계약 체결)
|
Korean | 10.8 KB | ||
| 2024-06-03 00:00 |
기업설명회(IR)개최
|
Korean | 7.2 KB |
Automate Your Workflow. Get a real-time feed of all Genome&Company filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genome&Company
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genome&Company via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
